Report Highlights
-
Emerging markets for the advanced medical technologies covered in this report was valued at $12.5 billion in 2008 and $13.5 billion in 2009. Growing at a compound annual growth rate (CAGR) of 12.7%, this market is expected to be valued at nearly $24.6 billion by 2014.
-
Surgical technologies represent the fastest growing market, increasing at a 21.5% compound annual growth rate, from $240 million in 2008 to $636 million in 2014.
-
Imaging and visualization technologies account for the largest percentage of sales, $5.9 billion (47.5% of the total) in 2008, approaching $9.4 billion (39% of the market) in 2014, a compound annual growth rate (CAGR) of 8.8%.
INTRODUCTION
- Identifying the medical device technologies and applications with the greatest commercial potential in the emerging markets over the near to mid-term (2008 to 2014).
- Analyzing the factors that will shape the emerging country market for advanced medical devices over the next 5 years.
- Estimating the current and future demand for specific types of medical device, by country.
- Identifying companies that are well-positioned to meet this demand, with an emphasis on companies that manufacture advanced medical equipment in the emerging markets.
- Imaging and visualization
- Patient monitoring
- Surgical devices
- Cardiovascular devices
- Orthopedic implants
- Renal devices
- Biochips
- Other advanced technologies (neurostimulators, implantable drug pumps, etc.).
- Summary
- The big emerging markets (BEMs): Demographics, economics, health care systems, medical equipment imports, and markets
- Types of advanced medical technologies and their applications
- Detailed market estimates and projections, by type of technology and country for the period 2008 to 2014
- Supplier profiles, with an emphasis on domestic manufacturers in the BEMs with the capability to compete with imports.
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to BCC’s industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers.
Recent Reports
In Vitro Diagnostics: Technologies and Global Markets
The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Routine Health Screening Market
The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Direct-to-Consumer Testing Industry: Global Markets
The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More